Cervical Artificial disc: Kineflex C
SI Joint Pain

Clinical Trials

Combination Of Lumbar Spinal Fusion And Artificial Disc Replacement (Hybrid Constructs) For Treatment Of Multilevel Lumbar Disc Disease.


Dr. Bitan is currently enrolling subjects in a non-sponsored research survey for patients diagnosed with two or three-level degenerative disc disease.

The vertebral column is composed of vertebrae and intervertebral discs. Following severe trauma or simply due to aging, discs may become dehydrated, causing the disc space to narrow and to compress. This phenomenon is called degenerative disc disease (DDD), and can cause back pain, back spasms, leg pain, numbness, or weakness.

The current standard for treatment of DDD is a spinal fusion, which consists of fusing two or more vertebrae together using bone grafts and instrumentation.

Another treatment option is that of an artificial disc replacement (ADR), which consists of removing the degenerated disc from between the vertebrae, and replacing it with a metal implant. The most standard type of artificial disc is called the Charité disc, which has been FDA approved since 2004.

The Hybrid procedure is a surgery performed by Dr. Bitan to treat multilevel lumbar (lower back) DDD. It combines the insertion of an artificial disc at one level, and a fusion at one or two adjacent levels, depending on the extent of the degeneration.

In order to better track patients' response and progress following this procedure, patients are asked to participate in a survey. Patients are asked to provide data that will be rigorously tracked in order to assess the benefits of the procedure. These results will be compared to those of double and triple-level fusions, standard treatment for multilevel DDD.

Participation in this survey will include:
  • Filling out questionnaires and taking X-Rays prior to the surgery and at regular intervals following the surgery: 2 weeks, 6 weeks, 3 months, 6 months, 12 months, 24 months.

Research conducted at:
Lenox Hill Hospital
130 East 77th Street, 7th floor
New York, NY, 10021

Contact information:
Tom Ross, Research Coordinator
(212) 744-8114 ext. 238

Privacy | Legal | Copyright © 2019 bitanmd.com